This NDC is on FDA's drug shortage list (posted Mar 10, 2023)
Reported reason: Other
Product Information
CLONAZEPAM 0.5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0197 per EA under NDC 00093083205. Its NADAC has been published 649 times since Nov 28, 2013.
FDA first approved this application on Sep 10, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093083205
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA074569FDA Approved
9/10/1996
TE Code
AB
On Market Since
9/18/1996
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.5 MG TABLET has been published 649 times since Nov 28, 2013, and over the history we have for it it has risen 20.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0197 per EA |
|---|---|
| All-time high | $0.0302 (Jul 12, 2023) |
| All-time low | $0.0154 (Jan 18, 2017) |
| 52-week high | $0.0224 |
| 52-week low | $0.0197 |
| Median price | $0.0209 |
| Average price | $0.0211 |
| Largest weekly change | -34.1% (Nov 20, 2024) |
| Weeks tracked | 649 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0197 per EA (NDC 00093083205), effective Aug 19, 2026.
How has the price of CLONAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.5 MG TABLET has risen 20.9%. It has been tracked across 649 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.5 MG TABLET?
Since Nov 28, 2013, the NADAC for CLONAZEPAM 0.5 MG TABLET has ranged from a low of $0.0154 (Jan 18, 2017) to a high of $0.0302 (Jul 12, 2023), with a median of $0.0209 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.5 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLONAZEPAM 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLONAZEPAM 0.5 MG TABLET?
CLONAZEPAM 0.5 MG TABLET (NDC 00093083205) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is CLONAZEPAM 0.5 MG TABLET in shortage?
Yes — NDC 00093083205 is currently listed in FDA's drug shortage database (posted Mar 10, 2023). Reported reason: Other.